| CTRI Number |
CTRI/2020/01/022915 [Registered on: 22/01/2020] Trial Registered Prospectively |
| Last Modified On: |
07/01/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison between hourly intermittent Epidural bolus and continuous epidural infusion of 0.1% Levobupivacaine AND Fentanyl for analgesia in labor. |
|
Scientific Title of Study
|
Comparison between intermittent Epidural bolus and continuous Epidural infusion of 0.1% levobupivacaine and fentanyl combination for labor analgesia. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Surinder kaur |
| Designation |
Junior Resident |
| Affiliation |
Government Medical College and Rajindra hospital |
| Address |
Department of Anaesthesia
Government Medical College and Rajindra hospital,
Patiala
Patiala PUNJAB 144202 India |
| Phone |
9915176132 |
| Fax |
|
| Email |
dr_surinder18@yahoo.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Tripat Kaur Bindra |
| Designation |
Professor |
| Affiliation |
Government Medical College and Rajindra hospital |
| Address |
Department of Anaesthesia
Government Medical College and Rajindra hospital,
Patiala.
Patiala PUNJAB 147001 India |
| Phone |
9501017040 |
| Fax |
|
| Email |
tripat_noori@yahoo.co.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Tripat Kaur Bindra |
| Designation |
Professor |
| Affiliation |
Government Medical College and Rajindra hospital |
| Address |
Department of Anaesthesia
Government Medical College and Rajindra hospital,
Patiala
Patiala PUNJAB 147001 India |
| Phone |
9501017040 |
| Fax |
|
| Email |
tripat_noori@yahoo.co.in |
|
|
Source of Monetary or Material Support
|
| Government medical college and rajindra hospital,Patiala(Punjab) |
|
|
Primary Sponsor
|
| Name |
Department of anaesthesiology and intensive care |
| Address |
Government college and rajindra hospital ,patiala |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Surinder kaur |
Government Medical college and Rajindra hospital |
Department of Anaesthesia and intensive care,
Government medical college and Rajindra hospital,Patiala Patiala PUNJAB |
9915176132
dr_surinder18@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Government Medical college,Patiala |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Epidural labor analgesia |
Intermittent epidural bolus an hourly versus continuous epidural infusion of 0.1% levobupivacaine and fentanyl 2 mcg/ml combination for labor analgesia till the time of delivery of the baby. |
| Comparator Agent |
not applicable |
not applicable |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Female |
| Details |
parturient with single pregnancy.
Cervical dilatation of 3-5 cm.
Cephalic presentation
Gestation >37 weeks |
|
| ExclusionCriteria |
| Details |
Breech presentation
Antepartum Haemorrhage
Severe Pre eclampsia
Multiple pegnancies
Cephalopelvic disproportion
Bleeding disorders
Decreased platelet counts
Sepsis
Aortic stenosis
Diabetes
Fetal distress
Imminent delivery
spinal column deformity
Spine surgery
Contraindication to epidural analgesia
History of anaphylaxis to local anaeshetics and allergy to drug to be administered. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Level of analgesia |
Till the time of delivery of the baby. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Total drug requirement ,Mode of delivery, Postpartum complications |
48 hours after delivery. |
|
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
27/01/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
The present randomized study will be conducted on 80 women in labour, belonging to ASA grade I or II, more than 36 weeks of gestation, at 3- 5 cm cervical dilatation, single pregnancy with cephalic presentation, who requested for labour analgesia at Rajindra Hospital, Patiala. The patients will be allocated randomly to 2 groups. Group A: Parturient will be given 10 ml of 0.1% Levobupivacaine (plain ) with Fentanyl 50 mcg and then 8 ml of 0.1% Levobupivacaine (plain ) and fentanyl 2 mcg / ml solution as epidural bolus every hour. Group B: Parturient will be given 10 ml of 0.1% levobupivacaine (plain ) with fentanyl 50 mcg and then 8 ml /hour of 0.1% Levobupivacaine (plain ) with fentanyl 2 mcg / ml as continuous epidural infusion. After administration of the drug,pain intensity, level of sensory block, degree of motor block, total drug requirement ,hemodynamic variables, mode of delivery, duration of second stage,neonatal outcome and side effects and post partum complications will be compared in both the groups. |